NCH2 Stock Overview
Engages in the engineering, procurement, and construction of electrochemical plants in Germany, Italy, Japan, China, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
thyssenkrupp nucera AG & Co. KGaA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €8.39 |
52 Week High | €18.91 |
52 Week Low | €7.78 |
Beta | 0 |
11 Month Change | -10.60% |
3 Month Change | -7.50% |
1 Year Change | -49.34% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -65.10% |
Recent News & Updates
Recent updates
Shareholder Returns
NCH2 | AT Construction | AT Market | |
---|---|---|---|
7D | 3.5% | 1.3% | -0.1% |
1Y | -49.3% | 7.5% | 2.9% |
Return vs Industry: NCH2 underperformed the Austrian Construction industry which returned 6.8% over the past year.
Return vs Market: NCH2 underperformed the Austrian Market which returned 2.5% over the past year.
Price Volatility
NCH2 volatility | |
---|---|
NCH2 Average Weekly Movement | 5.7% |
Construction Industry Average Movement | 4.3% |
Market Average Movement | 3.6% |
10% most volatile stocks in AT Market | 6.5% |
10% least volatile stocks in AT Market | 1.8% |
Stable Share Price: NCH2's share price has been volatile over the past 3 months compared to the Austrian market.
Volatility Over Time: NCH2's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1960 | 944 | Werner Ponikwar | thyssenkrupp-nucera.com |
thyssenkrupp nucera AG & Co. KGaA engages in the engineering, procurement, and construction of electrochemical plants in Germany, Italy, Japan, China, and internationally. The company offers green hydrogen, chlor- alkali, and hydrochloric acid solutions. It serves chemical and steel industries, as well as refineries.
thyssenkrupp nucera AG & Co. KGaA Fundamentals Summary
NCH2 fundamental statistics | |
---|---|
Market cap | €1.06b |
Earnings (TTM) | €5.70m |
Revenue (TTM) | €771.40m |
186.4x
P/E Ratio1.4x
P/S RatioIs NCH2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NCH2 income statement (TTM) | |
---|---|
Revenue | €771.40m |
Cost of Revenue | €686.70m |
Gross Profit | €84.70m |
Other Expenses | €79.00m |
Earnings | €5.70m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 13, 2025
Earnings per share (EPS) | 0.045 |
Gross Margin | 10.98% |
Net Profit Margin | 0.74% |
Debt/Equity Ratio | 0% |
How did NCH2 perform over the long term?
See historical performance and comparison